Latest total liabilities for SNPHF: $120B.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
As of the most recent data (September 2026), SNPHF shows a total liabilities of $120B. That compares with $780M in the prior-year period — up 14640.3% year over year. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, SNPHF's total liabilities is now $120B (was $780M) — a 14640.3% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Santen Pharmaceutical , Ltd. is outperforming or lagging.
Tracking SNPHF's total liabilities over time shows whether Santen Pharmaceutical , Ltd. is scaling, shrinking, or reshaping that part of the business. The current reading is $120B That compares with $780M in the prior-year period — up 14640.3% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this total liabilities page, Stockcircle has Santen Pharmaceutical , Ltd.'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total liabilities (currently $120B) with ownership activity and broader fundamentals.